Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease
Association of Cardiovascular Disease With Respiratory Disease
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics.
Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association